Urine Beta-Thromboglobulin Concentration or Beta-Thromboglobulin/Creatinine Ratio in Single Voided Urine Samples Cannot Be Reliably Used to Estimate Quantitative Beta-Thromboglobulin Excretion

Summary

Different procedures are currently used in the urine beta-thromboglobulin (BTG) assay. We investigated the reliability of limited urine collections and of different expressions of urine BTG results (concentration, urine BTG/creatinine ratio) for the measurement of hourly or daily BTG excretion rates. BTG was measured by a sensitive RIA method in various urine collections of normal subjects (n.80) and patients (n.120) with miscellaneous diseases where an enhanced in-vivo platelet activation could be expected. The BTG concentration in a 6-hour urine collection appeared to change in relation to the urine flow rate (r = -0.53 in normals, r = 0.27 in patients, p <0.01) and urine osmolality (r = 0.46 in normals, r = 0.31 in patients, p <0.01). In both normals and patients not a very good correlation was observed between the urine BTG/creatinine ratio and the BTG excretion rate (r = 0.54 and r = 0.48; p <0.001, respectively). Variable coefficients of correlation (r = 0.83-0.34) were observed between the BTG excretion rate of single voidings of the morning, afternoon-evening and night and the daily BTG excretion both in normals and patients. Reliable measurements of the BTG in urine should be expressed as the hourly excretion rate in a given period of the day for limited urine collections or as the daily excretion for 24-hour urine collections.

Key words

Urine beta - thromboglobulin

• References

• 1 Kaplan KL. Beta-thromboglobulin. Prog Haemost Thromb 1980; 5: 153-178
• 2 Zahavi J, Kakkar VV. Beta-thromboglobulin - a specific marker of in vivo platelet release reaction. Thromb Haemostas 1980; 44: 23-30
• 3 Dawes J, Smith RC, Pepper DS. The release, distribution, and clearance of human BTG and platelet factor 4. Thromb Res 1978; 12: 851-861
• 4 Anderton JL, Fananapazir L, Dawes J. Urinary BTG in essential hypertension. Br J Haematol 1980; 44: 307-311
• 5 Bolton AE, Cooke ED, Lekhwani CP, Bowcock SA. Urinary BTG levels as a diagnostic marker for post-operative deep vein thrombosis. Thromb Res 1980; 19: 249-255
• 6 De Boer AC, Turpie AG, Butt RW, Johnston RW, Genton E. Platelet release and thromboxane synthesis in symptomatic coronary artery disease. Circulation 1982; 66: 327-333
• 7 De Boer AC, Han P, Turpie AG, Butt RW, Zielinsky A, Genton E. Plasma and urine BTG concentration in patients with deep vein thrombosis. Blood 1981; 58: 693-698
• 8 Guzzo J, Niewiarowski S, Musial J, Bastl C, Grossman RA, Koneti Rao AA, Berman I, Dieter P. Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure. J Lab Clin Med 1980; 96: 102-113
• 9 Van Oost BA, Veldhuyzen B, Timmermans A, Sixma JJ. Increased urinary BTG excretion in diabetes assayed with a modified RIA kit-technique. Thromb Haemostas 1983; 49: 18-20
• 10 Bolton AE, Ludlam CA, Moore S, Pepper DS, Cash JD. Three approaches to the Radioimmunoassay of human Beta-thromboglobu-lin. Br J Haematol 1976; 33: 233-236
• 11 Bastl CP, Musial J, Kloczewiak M, Guzzo J, Berman I, Niewiarowski S. Role of kidney in the catabolic clearance of human platelet antiheparin proteins from rat circulation. Blood 1981; 57: 233-238
• 12 Hope W, Martin TJ, Chesterman CN, Morgan FJ. Human BTG inhibits PGI production and binds to a specific site in bovine aortic endothelial cells. Nature 1979; 282: 210-212
• 13 Gaudio KM, Siegel NI, Hayslett JP, Kashgarian M. Renal perfusion and intratubular pressure during ureteral occlusion in rat. Am J Physiol 1980; 238: 205
• 14 Katz AL, Emmanoel DS. Metabolism of polypeptide hormones by the normal kidney and in uremia. Nephron 1978; 22: 69-73
• 15 Camara AA, Arn KD, Reimer A, Newburgh LH. The twenty four-hour endogenous creatinine clearance as a clinical measure of the functional state of the kidneys. J Lab Clin Med 1951; 37: 743-763